Kolexia
Toulmonde Maud Oncologie médicale
Toulmonde Maud
Oncologie médicale
Institut Bergonié
Bordeaux, France
252 Activités
325 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Tumeurs des tissus mous Léiomyosarcome Récidive tumorale locale Métastase tumorale Tumeurs stromales gastro-intestinales Ostéosarcome Liposarcome Tumeurs osseuses

Collaborateurs

Voir plus
Italiano Antoine
Italiano Antoine
Institut Bergonié, Bordeaux, France
Blay Jean Yves
Blay Jean Yves
Centre Léon-Bérard, Lyon, France
Le Cesne Axel
Le Cesne Axel
Gustave-Roussy, Villejuif, France
Bompas Emmanuelle
Bompas Emmanuelle
Institut de cancérologie de l'Ouest, Saint-Herblain, France

Industries

Voir plus
GSK
2 collaboration(s)
Dernière en 2022
Pharma Mar
2 collaboration(s)
Dernière en 2023
BMS
1 collaboration(s)
Dernière en 2022
Adept Field Solutions
1 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
CRYODESMO-02: A Phase II Multicentric, Randomized Trial Assessing Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting
Essai Clinique (CHU Strasbourg)   15 mars 2024
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide.
Molecular cancer   20 février 2024
ChonDRAgon: A Randomized, Blinded, Placebo-controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma
Essai Clinique (Inhibrx, Inc.)   20 février 2024
Impact of metronomic trabectedin combined with low-dose cyclophosphamide on sarcoma microenvironment and correlation with clinical outcome: results from the TARMIC study.
Molecular cancer   19 février 2024
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
Improved nationwide survival of sarcoma patients with a network of reference centers.
Annals of oncology : official journal of the European Society for Medical Oncology   19 janvier 2024
Handling missing covariates in observational studies: an illustration with the assessment of prognostic factors of survival outcomes in soft-tissue or visceral sarcomas in irradiated fields (SIF).
Therapeutic advances in medical oncology   19 janvier 2024
AMPHISARC: A Multicenter, Phase I/II Study Evaluating the Clinical Impact of HDM201 + Pazopanib in Patients With P53 Wild-type Advanced/ Metastatic Soft Tissue Sarcomas (AMPHISARC)
Essai Clinique (Centre Léon-Bérard)   06 décembre 2023
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.
European journal of cancer (Oxford, England : 1990)   23 novembre 2023
MegaMOST - A Multicenter, Open-label, Biology Driven, Phase II Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations /Characteristics in Advanced / Metastatic Tumors.
Essai Clinique (Centre Léon-Bérard)   16 novembre 2023